Study of KarXT + KarX-EC for autism-related irritability in kids
Part of Mental health clinical trials.
This trial tests whether a combination of two medications (KarXT and KarX-EC) can help reduce irritability in children and teens with autism. It's for those who have significant irritability symptoms that affect daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child or teen, ages not specified, with a diagnosis of autism (ASD).
- Your irritability symptoms must be moderate to severe, as measured by specific rating scales.
- You cannot have bipolar disorder, schizophrenia, major depression, or PTSD as your main condition.
- You may have ADHD if it's not the main issue and is well-controlled.
- You must not have other serious medical or lab problems, or be at risk for suicide.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called Lumateperone to see if it can reduce irritability in children and teens with autism. It's a 3-month trial that compares the study drug to a placebo (a pill with no active medicine) to find out if it helps with mood and behavior.
This trial tests a combination of two drugs, KarXT and KarX-EC, to see if they can reduce irritability in children and teens with autism spectrum disorder. If your child has significant irritability linked to their autism, this study may offer a new treatment option.
This study tests an investigational medication called lumateperone to see if it can reduce irritability in children and teens with autism. It is for teenagers aged 13–17 whose irritability is causing significant problems.
This trial looks at the long-term safety of KarXT, a medication for schizophrenia, and KarX-EC for irritability related to autism in teenagers. It is for teens who have already completed the main part of a previous study without serious side effects.
This trial tests if a new medicine, KarXT, can safely and effectively treat schizophrenia in adolescents. It may help teenagers who have active symptoms like hallucinations or disorganized thinking.
This trial tests a new medicine, KarXT, to see if it can safely treat manic episodes in people with bipolar I disorder. It is for patients who are currently hospitalized for a manic episode that started within the last 3 weeks.
Hear when a new Irritability Associated With Autism Spectrum Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.